Pheast Therapeutics

2023 Rising Leaders Haig Aghajanian Jared Baeten Amira Barkal Ashleigh Batchen Jesse Chen Anthony DeBoer Lisa Deschamps Cécile Dupont Alexandra Ekman Ryding Christoffer Ekström David Fajgenbaum Jessic

Venture capital investors continue to show their enthusiasm for drug development, despite the relative pessimism of their peers investing in publicly traded biopharmaceutical companies, by putting the

It took four weeks, but the second quarter of 2022 finally has its first two biopharmaceutical initial public offerings in the US, launched by HilleVax, Inc. and Belite Bio late on 28 April. The o